APA (7th ed.) Citation

Schütz, C., Saußele, S., Dietz, C., Müller, M. C., & Hehlmann, R. (2017). Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML. Leukemia, 31(4), . https://doi.org/10.1038/leu.2017.9

Chicago Style (17th ed.) Citation

Schütz, Christian, Susanne Saußele, Christian Dietz, Martin Christian Müller, and Rüdiger Hehlmann. "Expression of the CTLA-4 Ligand CD86 on Plasmacytoid Dendritic Cells (pDC) Predicts Risk of Disease Recurrence After Treatment Discontinuation in CML." Leukemia 31, no. 4 (2017). https://doi.org/10.1038/leu.2017.9.

MLA (9th ed.) Citation

Schütz, Christian, et al. "Expression of the CTLA-4 Ligand CD86 on Plasmacytoid Dendritic Cells (pDC) Predicts Risk of Disease Recurrence After Treatment Discontinuation in CML." Leukemia, vol. 31, no. 4, 2017, https://doi.org/10.1038/leu.2017.9.